You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 62 No. 1, July 1959 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Penetrating Keratoplasty in Rabbits

Effects of Beta-Propiolactone (BPL) Treatment of Donor Corneal Discs

ALBERT C. JOHNSTON, M.D.; CORNELIUS E. McCOLE, M.D.; GERALD A. LoGRIPPO, M.D.

AMA Arch Ophthalmol. 1959;62(1):134-136.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The problem of a storage technique for corneal tissue which will not impair its suitability for keratoplasty has been well reviewed recently,1-4 and so any detailed consideration may be omitted. Suffice it to say that techniques involving freezing or freezing followed by dehydration of corneal material pretreated with glycerine represent substantial progress. However, a completely satisfactory solution of the problem remains to be achieved.

The chemical agent BPL (β-propiolactone) has been used successfully and apparently advantageously in the preparation for storage of arterial tissue to be used for arterial homografts.5 A freshly prepared 1% solution of BPL is an effective virucide, bacteriocide, sporicide, and fungicide; however, after two hours at 38 C the initially toxic BPL has completely hydrolyzed into nontoxic degradation products. It has proved feasible to sterilize contaminated arterial homografts with BPL without destroying their usefulness as functional transplants.

We deemed it worth while to investigate . . . [Full Text PDF of this Article]


Author Affiliations

Detroit

From the Department of Ophthalmology, Henry Ford Hospital.


Footnotes

Submitted for publication Jan. 23, 1959.

This investigation was supported by a research grant from the National Institutes of Health.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1959 American Medical Association. All Rights Reserved.